F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to prevent medication administration error rate of
5% or greater for 2 of 4 residents sampled for medication administration, (#37,#16). There were 2
medication errors in 27 opportunities for a medication error rate of 7.41%.
Residents Affected - Few
Findings:
1. Review of resident #37's medical record revealed she was admitted to the facility on [DATE] and
readmitted on [DATE]. Her diagnoses included osteoarthritis and fracture of the right femur.
On 7/26/23 at 9:20 AM, Licensed Practical Nurse (LPN) A prepared to administer resident #37's nine
scheduled morning medications and placed a total of 9 pills into a small plastic cup. LPN A then
approached resident #37 with the cup of 9 pills and the resident declined to take the Acetaminophen 325
milligrams (mg) tablet stating that she was not in pain. LPN A then went out to the medication cart and with
a spoon took out the single Acetaminophen 325 mg tablet and then returned to resident #37's room and
administered the remaining medications by mouth to the resident.
A review of resident #37's medical record post medication administration revealed an order for
Acetaminophen oral tablet 325 mg give 2 tablets by mouth four times a day for hip and back pain.
On 7/26/23 at 11:42 AM, a follow up interview was conducted with LPN A. The LPN read in the MAR
(medication administration record) for resident #37 an order for routine Acetaminophen 325 mg 2 tablets.
The nurse acknowledged medication error as she only brought one tablet to administer with the resident's
routine morning medications. LPN A explained, she usually read the orders twice to avoid making errors but
didn't today.
2. Resident #16 was admitted to the facility on [DATE] and re-admitted on [DATE] with diagnoses including
chronic obstructive pulmonary disease (COPD).
On 7/26/23 at 9:35 AM, medication administration was observed for resident #16 and LPN B. LPN B was
observed preparing the morning medications for resident #16 by placing pills in small plastic cup and taking
a boxed inhaler out of the medication cart. The inhaler box label read, Breo Ellipta 100/25 mcg
[micrograms]. The LPN proceeded to administer the medications to resident #16.
A record review post medication administration for resident #16 revealed an order dated 1/5/23 that read,
Breo Ellipta Aerosol Powder Breath Activated 200-25 mcg/inh (Fluticasone Furoate-Vilanterol) 1 puff inhale
orally one time a day at 9 AM for COPD.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
105797
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105797
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/29/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Guardian Care Nursing & Rehabilitation Center
350 South John Young Parkway
Orlando, FL 32805
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
On 7/26/23 at 9:23 AM, a follow up interview was conducted post medication administration with LPN B
who verified the order in the MAR for resident #16's inhaler medication read, Breo Ellipta 200/25 mcg, and
100/25 mcg was dispensed by the pharmacy instead of the physician ordered dose. LPN B could not
explain why she did not call the physician to clarify orders prior to administering the incorrect dose to
resident #16.
Residents Affected - Few
BREO ELLIPTA is used to treat asthma and chronic obstructive pulmonary disease.
(https://www.medsafe.gov).
On 7/26/23 at 11:47 AM, the Director of Nursing (DON) verified the nurses should triple check orders while
preparing medication to ensure no medication errors, first by reading the mediation label, second by looking
at the MAR and then third by reading the label again while preparing medications for administration.
Review of the facility's policy and procedure which was undated for Medication Administration read,
Purpose: To administer the 1. Right Medication 2. In the Right Dose .Equipment: Medication as ordered .7.
Read the Medication Administration Record (MAR) for the ordered medication, dose, route, and time .9.
Verify the pharmacy prescription label on the drug and the manufacturer's identification system matches
the MAR. If there is a discrepancy, check the original physician order and notify the pharmacy. [NAME] does
not give the medication until clarified .10. Verify the correct medication, expiration date, dose, route, and
time again before administering .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105797
If continuation sheet
Page 2 of 2